Current Opinion in Hematology

Papers
(The TQCC of Current Opinion in Hematology is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Posttransplant cyclophosphamide: a universal graft versus host disease prophylaxis38
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia26
Novel blood derived hemostatic agents for bleeding therapy and prophylaxis24
Deficits in our understanding of natural killer cell development in mouse and human23
Heme- and iron-activated macrophages in sickle cell disease: an updated perspective21
Age-dependent regulation of hematopoiesis by megakaryocytes21
Adenosine signaling in promoting the balance between erythropoiesis and myelopoiesis20
Interferon regulatory factor-8-dependent innate immune alarm senses GATA2 deficiency to alter hematopoietic differentiation and function20
Disparities in acute myeloid leukemia treatments and outcomes18
Mesenchymal stromal cells: an update18
Developmental regulation of primitive erythropoiesis17
Limitations of rituximab in treating primary immune thrombocytopenia and the therapeutic potentials of alternatives16
Megakaryocytes as mitochondria factories: potential donors for mitochondria transplantation16
The impact of obesity-induced inflammation on clonal hematopoiesis15
Platelet lifespan and mechanisms for clearance15
Unraveling lipid metabolism for acute myeloid leukemia therapy14
Confronting high-complexity situations in myeloproliferative neoplasms: from treating young patients to TP53-mutated and ‘unclassifiable’ entities14
Humanized murine models of platelet function13
Navigating prognostic stratification and approach to TP53-mutated myeloid neoplasms12
Multifaceted roles of CRISPR technology in blood cancer research12
Advances on the genetic basis of red cell membrane disorders11
High-throughput genotyping tools for red blood cell antigens11
Messengers of coagulopathy: complement-carrying extracellular vesicles in SARS-CoV-2 infection11
Shared host, distinct invaders: metabolomic footprints of plasmodium and babesia in host red cells11
Editorial introduction10
Haematopoietic stem cell quiescence exposed using mitochondrial membrane potential10
Targeting hemostatic enzymes: from mechanistic insights to therapeutic frontiers9
Cellular contributions to the pathogenesis of anti-platelet factor 4 disorders9
Hemostatic abnormalities in acute promyelocytic leukemia: clinical implications and mechanisms9
Tissue factor pathway inhibitor – cofactor-dependent regulation of the initiation of coagulation9
Signaling mechanisms and cis-regulatory control of Samd14 in erythroid regeneration9
Editorial introductions8
YY1 in hematopoietic stem cells: epigenetic regulation, chromatin architecture, and aging8
Understanding and targeting erythroid progenitor cells for effective cancer therapy8
Platelets in vascular inflammation: fire-fighters or pyromaniacs?8
Red cells: not only hemoglobin – plasma membranes are also of paramount importance8
Venous thromboembolism: diagnostic advances and unaddressed challenges in management7
Editorial introductions7
Protease-activated receptors in endothelial health and dysfunction7
Current Opinion in Hematology7
The immunology of PF4 polyanion interactions7
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods7
Modelling arterial thrombus formation in vitro7
Red blood cell changes due to cancer and cancer treatments: a narrative review6
Platelet transfusion6
PROTACs in platelets: emerging antithrombotic strategies and future perspectives6
A role of platelet C-type lectin-like receptor-2 and its ligand podoplanin in vascular biology6
Chediak-Higashi syndrome6
Platelets and platelet–leukocyte interactions in infectious diseases6
Membrane phospholipids in the regulation of tissue factor procoagulant function6
Challenges and opportunities in shared care for international patients treated with cellular therapy for nonmalignant disease6
Editorial introduction6
The state of prediction models in hematologic disease: a worrisome assessment6
The fulfilled promise and unmet potential of umbilical cord blood6
0.062081098556519